Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Resolve Therapeutics begins phase II study of RSLV-132 in SLE

July 18, 2014

Novartis patents new modified IGF-I polypeptides

July 17, 2014

SBIR grant supports Cel-Sci's development of LEAPS technology for RA

July 16, 2014

Clementia initiates phase II study of palovarotene for FOP

July 15, 2014

FDA grants orphan drug status to siponimod for dermatomyositis

July 15, 2014

Merck & Co. presents new SYK inhibitors

July 15, 2014

FDA approves Medac's autoinjectable subcutaneous methotrexate product

July 15, 2014

Celgene set to study CC-220 in pilot phase II trial for SLE

July 14, 2014

Hanmi presents promising results for HM-71224

July 14, 2014

Celgene reports data from phase III POSTURE study

July 10, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...